Pereira, M. J., Lundkvist, P., Kamble, P. G., Lau, J., Martins, J. G., Sjöström, C. D., . . . Eriksson, J. W. (2018). A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss. Diabetes Ther.
Chicago Stili AlıntıPereira, Maria J., et al. "A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals With Obesity and Without Diabetes: Metabolic Effects and Markers Associated With Bodyweight Loss." Diabetes Ther 2018.
MLA AlıntıPereira, Maria J., et al. "A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals With Obesity and Without Diabetes: Metabolic Effects and Markers Associated With Bodyweight Loss." Diabetes Ther 2018.